Literature DB >> 12006779

Human T cell lymphotropic virus type 1-associated myelopathy in São Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort.

Antonio C P Milagres1, Maria Lúcia S G Jorge, Paulo E Marchiori, Alusio A C Segurado.   

Abstract

We report epidemiologic and clinical features of human T cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis in a Brazilian cohort of 86 patients from a university hospital. Cerebrospinal fluid (CSF) abnormalities and magnetic resonance imaging (MRI) findings were correlated with neurologic signs and symptoms. The patients' mean age at disease onset was 43.2 years and the female to male ratio 1.5:1. Risk factors for retroviral exposure included blood transfusions, sexual transmission and intravenous drug use. Neurologic manifestations consisted mostly of spastic paraparesis, of gradual and asymmetric onset, with increased deep-tendon reflexes. Disability was associated with disease duration. CSF findings included mild mononuclear pleocytosis and elevated protein levels. MRI showed hemispheric areas of high signal intensity in 32.7% and spinal cord atrophy in 5.6% of cases, particularly in patients with longer duration of disease. A high frequency of past blood transfusion (32.6%) suggests that blood-borne infection was an important means of HTLV infection before implementation of screening of blood donors in Brazil. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12006779     DOI: 10.1159/000054813

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

1.  HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.

Authors:  Iordanis E Evangelou; Raya Massoud; Steven Jacobson
Journal:  J Neuroimaging       Date:  2012-02-03       Impact factor: 2.486

2.  Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.

Authors:  Francesca Bagnato; John A Butman; Carlos A Mora; Shiva Gupta; Yoshima Yamano; Talin A Tasciyan; Jeffrey M Solomon; Waldyr J Santos; Roger D Stone; Henry F McFarland; Steven Jacobson
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

3.  In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.

Authors:  Winston Liu; Govind Nair; Luisa Vuolo; Anshika Bakshi; Raya Massoud; Daniel S Reich; Steven Jacobson
Journal:  Ann Neurol       Date:  2014-07-22       Impact factor: 10.422

4.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

5.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

6.  CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Tomoo Sato; Ariella Coler-Reilly; Atae Utsunomiya; Natsumi Araya; Naoko Yagishita; Hitoshi Ando; Junji Yamauchi; Eisuke Inoue; Takahiko Ueno; Yasuhiro Hasegawa; Kusuki Nishioka; Toshihiro Nakajima; Steven Jacobson; Shuji Izumo; Yoshihisa Yamano
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

7.  Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.

Authors:  Massanobu Takatani; Myuki Esashika Crispim; Nelson Fraiji; Mariane Martins Araujo Stefani; Dagmar Kiesslich
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

Review 8.  Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Yoshimi Enose-Akahata; Steven Jacobson
Journal:  Retrovirology       Date:  2019-11-29       Impact factor: 4.602

9.  Quality of life and pain multidimensional aspects in individuals with HTLV-1.

Authors:  Maíra Carvalho Macêdo; Renata de Sousa Mota; Naiane Araújo Patrício; Ana Paula Campos Dos Santos; Selena Márcia Dubois Mendes; Cristiane Maria Carvalho Costa Dias; Abrahão Fontes Baptista; Katia Nunes Sá
Journal:  Braz J Infect Dis       Date:  2016-07-26       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.